Navigation Links
Brookhaven Lab's Joanna Fowler to be awarded National Medal of Science
Date:9/24/2009

UPTON, NY Joanna Fowler, a senior chemist and Director of the Radiotracer Chemistry, Instrumentation and Biological Imaging Program at the U.S. Department of Energy's Brookhaven National Laboratory, will be awarded the National Medal of Science at a White House ceremony on October 7. She is one of nine researchers named by President Barack Obama to receive the nation's highest award for lifetime achievement in science.

The National Medal of Science was created by statute in 1959 and is administered for the White House by the National Science Foundation. The annual award recognizes individuals who have made outstanding contributions to science and engineering. Nominees are selected by a committee of Presidential appointees based on their advanced knowledge in, and contributions to, the biological, behavioral/social, and physical sciences, as well as chemistry, engineering, computing and mathematics.

"This award is both humbling and gratifying," Fowler said. "It recognizes the importance of chemistry and imaging in advancing our knowledge of the human brain, particularly as it is affected by drugs, disease and aging."

Fowler has been a major contributor to brain research and the study of diseases such as addiction, which she has studied using an imaging technique called positron emission tomography (PET). In 1976, Fowler and her colleagues synthesized 18F-fluorodeoxyglucose (FDG), a radiotracer used in PET. Today, FDG is widely used in hospitals and research centers throughout the world to diagnose and study neurological and psychiatric diseases and to diagnose cancer.

In her recent research, Fowler has focused on changes in the brain circuits that are disrupted during drug addiction. Some of her studies included imaging the uptake and movement of cocaine and methamphetamine in the human brain, which shed light on why these drugs are so powerfully addictive. She is also involved in PET studies to understand the action of therapeutic drugs and facilitate the introduction of new drugs into the practice of medicine.

Another research area is centered on variations in monoamine oxidase (MAO) genes and how they affect personality and vulnerability to psychiatric disorders. In earlier research, Fowler discovered that cigarette smokers have reduced levels of MAO, an enzyme that breaks down dopamine, the neurotransmitter that mediates reward, motivation and movement. This finding may account for the high rate of smoking in individuals who are depressed or addicted to drugs.

After earning a B.A. in chemistry at the University of South Florida in 1964 and a Ph.D. in chemistry at the University of Colorado in 1967, Fowler carried out postdoctoral research at the University of East Anglia, in Norwich, England, and at Brookhaven Lab. Joining the Laboratory in 1969, Fowler has spent her entire career at Brookhaven.

Fowler's honors include the Society of Nuclear Medicine's Paul Aebersold Award and the Department of Energy's E. O. Lawrence Award, both received in 1997; the American Chemical Society's Francis P. Garvin-John M. Olin Medal in 1998; and the Glen T. Seaborg Award in 2002. She was elected to the National Academy of Sciences in 2004, and, earlier this year, she was honored with the National Academy of Sciences Award in Chemical Sciences and was inducted into the Long Island Technology Hall of Fame. Fowler has published about 350 peer-reviewed articles and holds eight patents for radiolabeling procedures.

Three other Brookhaven Lab researchers have been honored with the National Medal of Science: Donald D. Van Slyke (Biological Sciences, 1965), Maurice Goldhaber (Physical Sciences, 1983), and Raymond Davis (Physical Sciences, 2001).

Fowler's research is funded by the U.S. Department of Energy's Office of Science, which provides infrastructure support for technology development, and the National Institutes of Health.


'/>"/>

Contact: Diane Greenberg
greenbd@optonline.net
631-344-2347
DOE/Brookhaven National Laboratory
Source:Eurekalert

Related medicine news :

1. Brookhaven Lab and Hybridyne Imaging Technologies Inc., win R&D 100 award
2. Brookhaven Lab and BioSET patent a synthetic peptide that enhances bone growth
3. Brookhaven scientists explore brains reaction to potent hallucinogen
4. Monarch Labs to Demonstrate Maggot Therapy at Diabetic Limb Salvage Conference
5. New Reagents from New England Biolabs Bring Purity and Increased Value to Sample Prep for Next Generation Sequencing
6. Cord Blood America Nearing Completion of Construction of Las Vegas Laboratory; One of the Largest Cryogenic Storage Labs in U.S.
7. Mesa Labs Declares Quarterly Dividend
8. Mesa Labs Reports Higher First Quarter Earnings
9. GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
10. X4 Labs to Create Solid Gold Male Enhancement Device for Rich Saudi Man
11. Chesson Labs Liquid Bandage Product NUVADERM(TM) Receives FDA 510(k) Market Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture ... said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package ... Final Cut Pro X . Simply select a ProHand generator and drag it ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... On Friday, ... presented a Bronze Wellness at Work award to iHire in recognition of their exemplary ... part of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort ... holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain ... Disease (SCD) is a disorder of the red blood cells, which can cause episodes ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
Breaking Medicine Technology: